Overview

A Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee

Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
The Primary objective of this study is to evaluate the efficacy of VX-150 in the treatment of osteoarthritis pain
Phase:
Phase 2
Details
Lead Sponsor:
Vertex Pharmaceuticals Incorporated